The Hydration Pharmaceuticals Company Limited (HPC.AX)

AUD 0.01

(0.0%)

Operating Income Summary of The Hydration Pharmaceuticals Company Limited

  • The Hydration Pharmaceuticals Company Limited's latest annual operating income in 2023 was -7.74 Million USD , up 26.38% from previous year.
  • The Hydration Pharmaceuticals Company Limited's latest quarterly operating income in 2024 Q2 was -1.25 Million USD , down 0.0% from previous quarter.
  • The Hydration Pharmaceuticals Company Limited reported an annual operating income of -10.51 Million USD in 2022, down -97.42% from previous year.
  • The Hydration Pharmaceuticals Company Limited reported an annual operating income of -5.32 Million AUD in 2021, down -61.42% from previous year.
  • The Hydration Pharmaceuticals Company Limited reported a quarterly operating income of -1.25 Million USD for 2024 Q1, up 33.11% from previous quarter.
  • The Hydration Pharmaceuticals Company Limited reported a quarterly operating income of -1.87 Million USD for 2023 Q3, up 6.1% from previous quarter.

Annual Operating Income Chart of The Hydration Pharmaceuticals Company Limited (2023 - 2018)

Historical Annual Operating Income of The Hydration Pharmaceuticals Company Limited (2023 - 2018)

Year Operating Income Operating Income Growth
2023 -7.74 Million USD 26.38%
2022 -10.51 Million USD -97.42%
2021 -5.32 Million AUD -61.42%
2020 -3.29 Million USD 2.96%
2019 -3.4 Million USD 63.27%
2018 -9.25 Million USD 0.0%

Peer Operating Income Comparison of The Hydration Pharmaceuticals Company Limited

Name Operating Income Operating Income Difference
Metcash Limited 480.4 Million AUD 101.612%